A decreased expression of RORα in breast cancer fosters invasion and proliferation, enhances epithelial–mesenchymal transition (EMT), and triggers cancer-associated inflammation in the tumor microenvironment [9,10,16,17]. Here, RORA is linked to breast cancer.